{"id":"W4295078726","doi":"10.1200/jco.22.01549","title":"Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":475,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; NRG Oncology; Sanofi; AstraZeneca","keywords":"Olaparib; Medicine; PARP inhibitor; Internal medicine; Ovarian cancer; Hazard ratio; Clinical endpoint; Oncology; Placebo; Cancer; Veliparib; BRCA mutation; Clinical trial; Surgery; Poly ADP ribose polymerase; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002179637,0.0001772311,0.001160005,0.00009441567,0.0001478089,0.00001217312,0.0001758831,0.0001364124,0.000448143],"category_scores_gemma":[0.0009345552,0.000103304,0.0001749953,0.0002504745,0.0002944048,0.0001339617,0.00007866536,0.001233417,0.000001815685],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007488106,"about_ca_system_score_gemma":0.001994423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001006044,"about_ca_topic_score_gemma":0.0009058964,"domain_scores_codex":[0.9965121,0.0007310529,0.001436605,0.0002891139,0.0007279065,0.0003032893],"domain_scores_gemma":[0.9952398,0.002318377,0.001628557,0.0002185164,0.0003681385,0.0002266054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7321832,0.001613375,0.2398348,0.00001538597,0.000467736,0.0007390929,0.0007976691,0.00113173,0.0000121514,0.000289686,0.003683691,0.01923142],"study_design_scores_gemma":[0.5410072,0.03555233,0.3965478,0.0001344268,0.0001942548,0.0001262522,0.0003348113,0.00005206616,0.000004249408,0.0005021031,0.02539334,0.0001512317],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9829684,0.0001850977,0.0001138045,0.01338323,0.002006334,0.0008550347,0.00002133972,0.000008842786,0.0004579198],"genre_scores_gemma":[0.9923978,0.0002285536,0.001116289,0.005045392,0.0006198644,0.0001348221,0.000008043829,0.00002999538,0.0004191927],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.191176,"threshold_uncertainty_score":0.5358651,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0555831528157147,"score_gpt":0.3980408485949811,"score_spread":0.3424576957792664,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}